Wednesday, August 23, 2017

Axial Biotherapeutics Names New Executives

Pasadena- and Boston-based Axial Biotherapeutics, which is developing treatments for neurological diseases, said on Tuesday that it has named Srinivas G. Rao, M.D., Ph.D. as its Chief Medical Officer, Ryan Barrett as Vice President, Corporate Development and Intellectual Property, and Bridget M. Cole, Ph.D. as Vice President of Medicinal Chemistry. Rao was most recently CMO at DepoMed, and also served at Kyalin Biosciences, and was involved with Avalon Ventures, among other experience. Barrett was previously at OvaScience, and also has served at BioEnterprise Corp. Cole was previously at Flatley Discovery Lab, and also served at Surface Logix and Pfizer. All three will be based out of Axial's Boston offices.